Press release
Cardiometabolic Disease Market 2020 Global Size, Share, Growth Factor and Top Key Companies Cardax, Inc., Novartis AG, Novo Nordisk A/S, Eli Lilly and Company and More
The rise in prevalence of people suffering from cardiovascular diseases is creating lucrative growth opportunities for the global cardiometallic disease market, predicts Fortune Business Insights in their recent study. The study is named "Cardiometabolic Disease Market Size, Share and Global Trend by Treatment (Angiotensin-converting Enzyme (ace) Inhibitors, Diuretics, Glucophage), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Geography Forecast till 2026."Browse Complete Report: https://www.fortunebusinessinsights.com/industry-reports/cardiometabolic-disease-market-100207
Top Leaders Overview:
Some of the leading companies in the global Cardiometabolic Disease Market are
o Cardax, Inc.
o Novartis AG
o Novo Nordisk A/S
o Eli Lilly and Company
o Bayer AG
o Allergan
o Boehringer Ingelheim International GmbH
o AstraZeneca and
o other players.
Fortune Business Insights finds the ACE inhibitors segment to account for the largest share in the market. This is because of the implementation of ACE inhibitors for treating people with heart failure or hypertension. Again, due to the high prevalence of obesity and diabetes, the demand for ACE inhibitors is more and is likely to remain so in the coming years.
Rising Prevalence of Cardiovascular Diseases to Boost Market
Due to the rising incidences of cardiovascular problems worldwide, the demand for cardiometabolic drugs is increasing by the day. This demand is more in developing countries as compared to the already developed ones owing to the availability of skilled professionals. Such demands are likely to bode well for the global cardiometallic disease market in the coming years.
Other factors boosting the market are increasing geriatric and bariatric population and further increasing risk of cardiovascular diseases in them. This need for treating such patients is increasing the demand for cardiovascular devices and thus, boosts the global cardiometabolic market in the long run.
Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/cardiometabolic-disease-market-100207
The implementation of artificial intelligence and AI-predictive diagnostic tools along with adjunct therapies and digital therapeutics are also driving the market. Traditional drug treatment is replaced by behavioral and nutritional therapies and this will help the market for cardiometallic diseases witness progressive growth in the years to come.
Awareness and wellness programs conducted by governments worldwide is also adding boost to the market. The rising popularity of cardiac therapeutics will help the market gain momentum because their success rate is increasing and mortality rate is increasing. This will further fuel the market in the long run.
However, the adverse effects related post cardiac disease treatments may inhibit growth in the long run. The risk factors associated post heart surgery, the biggest among them being death, may hamper the market during the forecast period.
Nevertheless, the use of alternative therapeutics for the treatment of cardiometabolic diseases and disorders related to it such as hypertension, obesity, high pressure, and others will help the market offer lucrative growth opportunities for treatment of cardiac problems in future.
Companies Expanding Geographical Reach to Walk Ahead in Competition
The global market for cardiometabolic disease is currently dominated by Europe and North America on account of availability of skilled professionals, and presence of large number of market players in the regions. However, Asia Pacific will witness faster growth in the forecast duration due to the increasing number of healthcare infrastructure and rising awareness about cardiac problems and their therapeutic measures.
Major market vendors are putting efforts to expand their business geographically, especially in developing nations. This will not only provide better medical aid to people in the developing nations but also provide great scope for growth in the market. Other strategies adopted by market vendors are merger and acquisition, and huge investments in research and development. Some of the players operating in the global cardiometabolic disease market are Eli Lilly and Company, Novo Nordisk A/S, Allergan, Novartis AG, AstraZeneca, Boehringer Ingelheim International GmbH, Bayer AG, Cardax, Inc.
Get Customized at https://www.fortunebusinessinsights.com/enquiry/customization/cardiometabolic-disease-market-100207
Major Table of Content For Cardiometabolic Disease Market:
1. Introduction
2. Executive Summary
3. Market Dynamics
4. Key Insights
5. Global Cardiometabolic Disease Market Analysis, Insights and Forecast, 2026
6. North America Cardiometabolic Disease Market Analysis, Insights and Forecast, 2026
7. Europe Cardiometabolic Disease Market Analysis, Insights and Forecast, 2026
8. Asia Pacific Cardiometabolic Disease Market Analysis, Insights and Forecast, 2026
9. Middle East and Africa Cardiometabolic Disease Market Analysis, Insights and Forecast, 2026
10. Latin America Cardiometabolic Disease Market Analysis, Insights and Forecast, 2026
11. Competitive Landscape
12. Company Profile
13. Conclusion
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiometabolic Disease Market 2020 Global Size, Share, Growth Factor and Top Key Companies Cardax, Inc., Novartis AG, Novo Nordisk A/S, Eli Lilly and Company and More here
News-ID: 2034242 • Views: …
More Releases from Fortune Business Insights Private Limited
![Forensic Technology Market Size, Share, Trends, Growth & Industry Overview [2025-2032]](https://cdn.open-pr.com/L/5/L522889944_g.jpg)
Forensic Technology Market Size, Share, Trends, Growth & Industry Overview [2025 …
Forensic Technology Market: Trends, Growth, and Key Players in 2025
Market Overview
The forensic technology market is undergoing a transformative evolution driven by advancements in AI, digitalization, and increasing global crime rates. From crime scene investigation to DNA analysis and digital forensics, modern forensic tools are revolutionizing law enforcement and judicial systems. As governments and private entities invest heavily in advanced forensic solutions, the market is poised for robust growth through 2032.…

Dental Market Size, Share, Trends & Growth Report, 2032
The global dental market size was valued at USD 37.86 billion in 2024. The market is projected to grow from USD 41.03 billion in 2025 to USD 87.65 billion by 2032, exhibiting a CAGR of 11.5% during the forecast period. North America dominated the dental market with a market share of 39.06% in 2024.
The dental market refers to the industry that encompasses all businesses, products, and services related to oral…

Contraceptives Market Growing Rapidly With a CAGR of 5.5% by 2027
🌍 Contraceptives Market: Global Industry Insights, Trends & Forecast to 2027
🤖 Market Overview
The global contraceptives market has seen consistent growth over the past decade, driven by increased awareness around reproductive health, government initiatives promoting family planning, and technological advancements in birth control methods. As we move toward 2027, the market is projected to witness significant expansion, presenting lucrative opportunities for stakeholders, manufacturers, and investors.
This article offers a comprehensive analysis of…
Smart Inhalers Market Size, Share, Growth & Industry Report (2025-2032)
🌐 Market Overview
The smart inhalers market is poised for exponential growth, driven by increasing respiratory disorders, advancements in digital health, and the demand for personalized treatment. Smart inhalers, equipped with sensors and Bluetooth technology, help patients track dosage, adherence, and treatment effectiveness in real time. These devices are increasingly integrated with mobile health apps, improving both patient outcomes and physician monitoring. With healthcare systems shifting toward remote patient management, smart…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…